Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1

Trafficking of tissue dendritic cells (DCs) via lymph is critical for the generation of cellular immune responses in draining lymph nodes (LNs). In the current study we found that DCs docked to the basolateral surface of lymphatic vessels and transited to the lumen through hyaluronan-mediated intera...

Full description

Bibliographic Details
Main Authors:	Johnson, L, Banerji, S, Lawrance, W, Gileadi, U, Prota, G, Holder, K, Roshorm, Y, Hanke, T, Cerundolo, V, Gale, N, Jackson, D
Format:	Journal article
Language:	English
Published:	Springer Nature 2017

Similar Items

Binding of hyaluronan to the native lymphatic vessel endothelial receptor LYVE-1 is critically dependent on receptor clustering and hyaluronan organization
by: Lawrance, W, et al.
Published: (2016)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
by: Banerji, S, et al.
Published: (2016)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
by: Banerji, S, et al.
Published: (2016)

LYVE-1 and hyaluronan - a molecular velcro
by: Lawrance, W
Published: (2013)

The cortical actin network regulates avidity-dependent binding of hyaluronan by the Lymphatic Vessel Endothelial receptor LYVE-1
by: Stanly, TA, et al.
Published: (2020)

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.
by: Prevo, R, et al.
Published: (2001)

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.
by: Banerji, S, et al.
Published: (1999)

Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.
by: Banerji, S, et al.
Published: (2010)

A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium.
by: Nightingale, T, et al.
Published: (2009)

Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking
by: Jackson, D
Published: (2018)

Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1.
by: Johnson, L, et al.
Published: (2007)

Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
by: Trojan, L, et al.
Published: (2004)

The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1.
by: Jackson, D
Published: (2003)

Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.
by: Gale, N, et al.
Published: (2007)

LYVE-1, the lymphatic system and tumor lymphangiogenesis.
by: Jackson, D, et al.
Published: (2001)

TGFβ counteracts LYVE-1-mediated induction of lymphangiogenesis by small hyaluronan oligosaccharides
by: Bauer, J, et al.
Published: (2017)

Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen
by: Lim, H, et al.
Published: (2018)

Hyaluronan receptor LYVE-1 - expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen
by: Lim, Hwee Ying, et al.
Published: (2020)

The expression of the lymphatic endothelial cell marker LYVE-1 in benign and malignant vascular tumours
by: Edwards, J, et al.
Published: (2003)

High LYVE-1 positive lymphatic vessel numbers are associated with axillary lymph node metastases and poor outcome in breast cancer.
by: Bono, P, et al.
Published: (2004)

Dendritic cell entry to lymphatic capillaries is orchestrated by CD44 and the hyaluronan glycocalyx
by: Johnson, LA, et al.
Published: (2021)

Low molecular weight hyaluronan induces lymphangiogenesis through LYVE-1-mediated signaling pathways.
by: Man Wu, et al.
Published: (2014-01-01)

Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor (LYVE-1) by ocular surface cells.
by: Chen, L, et al.
Published: (2004)

FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake
by: Shikshya Shrestha, et al.
Published: (2020-07-01)

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
by: Cursiefen, C, et al.
Published: (2002)

High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer.
by: Bono, P, et al.
Published: (2004)

The interaction between LYVE-1 with hyaluronan on the cell surface may play a role in the diversity of adhesion to cancer cells.
by: Yan Du, et al.
Published: (2013-01-01)

DOES PERITUMORAL LYVE-1 IMMUNOREACTIVITY PREDICT THE SENTINEL LYMPH NODE METASTASIS?
by: Hilal Koçdor, et al.
Published: (2006-01-01)

LYVE-1 expression in the endothelium of newly formed vessels of carotid atherosclerotic plaque
by: Anna N. Evdokimenko, et al.
Published: (2020-09-01)

A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity.
by: Kato, T, et al.
Published: (2005)

Prostaglandin E<sub>2</sub> Boosts the Hyaluronan-Mediated Increase in Inflammatory Response to Lipopolysaccharide by Enhancing Lyve1 Expression
by: Pauline Hog, et al.
Published: (2023-11-01)

Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas.
by: Vainionpää, N, et al.
Published: (2007)

Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.
by: Heinzelbecker, J, et al.
Published: (2013)

Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells
by: Fabienne Burger, et al.
Published: (2022-01-01)

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
by: Koukourakis, M, et al.
Published: (2005)

Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis.
by: Jackson, D
Published: (2004)

Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
by: Williams, C, et al.
Published: (2003)

Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan.
by: Wolny, P, et al.
Published: (2010)

Analysis of CD44 hyaluronan-binding domain mutants by NMR
by: Wright, A, et al.
Published: (2004)

Hyaluronan and lymphedema.
by: Jackson, D
Published: (2004)